ERp29 as a regulator of Insulin biosynthesis

Jeffrey Viviano(Children's Hospital of Philadelphia), Ronald C. Rubenstein(West Chester University)

PLoS ONE

May 20, 2020

10.1371/journal.pone.0233502

Cited by 10

Related Papers

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation

|New England Journal of Medicine|2010|802

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation

|Thorax|2011|496